Cargando…

The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells

PURPOSE: Glioblastoma multiforme (GBM) is the most malignant primary type of brain tumor in adults. There has been increased focus on the immunotherapies to treat GBM patients, the therapeutic value of natural killer (NK) cells is still unknown. Programmed death-1 (PD-1) is a major immunological che...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Bo Yuan, Zhan, Yi Ping, Zong, Wen Jing, Yu, Chun Jiang, Li, Jun Fa, Qu, Yan Ming, Han, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534134/ https://www.ncbi.nlm.nih.gov/pubmed/26266810 http://dx.doi.org/10.1371/journal.pone.0134715

Ejemplares similares

PD-1-positive Natural Killer Cells have a weaker antitumor function than that of PD-1-negative Natural Killer Cells in Lung Cancer
por: Niu, Chao, et al.
Publicado: (2020)

Burgeoning Exploration of the Role of Natural Killer Cells in Anti-PD-1/PD-L1 Therapy
por: Bai, Rilan, et al.
Publicado: (2022)

Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model
por: Liu, Wai Nam, et al.
Publicado: (2022)

Heterogeneity of natural killer cells in the mouse
Publicado: (1981)

PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells
por: Guo, Yanan, et al.
Publicado: (2016)

The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy
por: Quatrini, Linda, et al.
Publicado: (2020)

Thy-1+ and Thy-1- natural killer cells. Only Thy-1- natural killer cells suppress dendritic cells
Publicado: (1986)

PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment
por: Hassan, Syeda S., et al.
Publicado: (2015)

PD-L1/PD-1 blockage enhanced the cytotoxicity of natural killer cell on the non-small cell lung cancer (NSCLC) by granzyme B secretion
por: Qiao, Duan-Rui, et al.
Publicado: (2023)

Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma
por: Zhang, Xue-wen, et al.
Publicado: (2020)

Immunotherapy of Hepatocellular Carcinoma with Magnetic PD-1 Peptide-Imprinted Polymer Nanocomposite and Natural Killer Cells
por: Lee, Mei-Hwa, et al.
Publicado: (2019)

Increased Frequency of Dysfunctional Siglec-7(−)CD57(+)PD-1(+) Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease
por: Sakamoto, Yuzuru, et al.
Publicado: (2021)

Natural Killer T Cells in Various Mouse Models of Hepatitis
por: Guan, Jun, et al.
Publicado: (2021)

Natural killer cells and natural killer T cells in Lyme arthritis
por: Katchar, Kia, et al.
Publicado: (2013)

VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma
por: He, Hai-Xia, et al.
Publicado: (2021)

Combination of Anti-PD-1 Antibody, Anlotinib and Pegaspargase “Sandwich” With Radiotherapy in Localized Natural Killer/T Cell Lymphoma
por: Sun, Peng, et al.
Publicado: (2022)

The Role of PD-L1 Expression in Prediction and Stratification of Recurrent or Refractory Extranodal Natural Killer/T-Cell Lymphoma
por: Gao, Li-Min, et al.
Publicado: (2022)

The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function
por: Balasko, Allison L., et al.
Publicado: (2023)

Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer
por: Youn, Je-In, et al.
Publicado: (2020)

Histidine‐rich glycoprotein augments natural killer cell function by modulating PD‐1 expression via CLEC‐1B
por: Nishimura, Yoshito, et al.
Publicado: (2019)

Predicting treatment response of patients with extranodal natural killer/T‐cell lymphoma based on levels of PD‐L1 mRNA and soluble PD‐L1
por: Feng, Yu, et al.
Publicado: (2020)

Roles of Natural Killer T Cells and Natural Killer Cells in Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2019)

NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells
por: Foltz, Jennifer A., et al.
Publicado: (2016)

Natural killer T cells
por: Kanellopoulos, Jean
Publicado: (2015)

Silk peptide treatment potentiates natural killer cell activity in vitro and induces natural killer cell maturation and activation in mouse splenocytes
por: Jang, Sun-Hee, et al.
Publicado: (2019)

Natural killer cell-related gene signature predicts malignancy of glioma and the survival of patients
por: Li, Chenglong, et al.
Publicado: (2022)

Infections, Reactions of Natural Killer T Cells and Natural Killer Cells, and Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2022)

Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma
por: Eckel‐Passow, Jeanette E., et al.
Publicado: (2019)

Mouse Cytomegalovirus infection overrules T regulatory cell suppression on natural killer cells
por: Lindenberg, Marc, et al.
Publicado: (2014)

Cytochrome P450 26A1 modulates natural killer cells in mouse early pregnancy
por: Meng, Chao‐Yang, et al.
Publicado: (2016)

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
por: Nakashima, Hiroyuki, et al.
Publicado: (2023)

Natural killer cell status and tolerance in mouse and human bacterial sepsis
por: Souza-Fonseca-Guimaraes, F, et al.
Publicado: (2012)

Treatment of solid tumor with autologous natural killer cells in mouse models
por: Liao, Nan-Shih
Publicado: (2014)

Impact of Aging on the Phenotype of Invariant Natural Killer T Cells in Mouse Thymus
por: Papadogianni, Georgia, et al.
Publicado: (2020)

Transcriptional Regulation of Mouse Tissue-Resident Natural Killer Cell Development
por: Valero-Pacheco, Nuriban, et al.
Publicado: (2020)

Uterine Natural Killer Cell Heterogeneity: Lessons From Mouse Models
por: Sojka, Dorothy K.
Publicado: (2020)

Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma
por: Cai, Jun, et al.
Publicado: (2020)

GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer/T cell lymphoma
por: Rong, Qi-xiang, et al.
Publicado: (2021)

The co-inhibitory immune checkpoint proteins B7-H1(PD-L1) and B7-H4 in high grade glioma: From bench to bedside
por: Qi, Ying, et al.
Publicado: (2023)

Function of PD-L1 in antitumor immunity of glioma cells
por: Lou, Yongli, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8ag6dpgdhhlmeke5e42kkbu39a